2 FTSE 100 Actions that investors should consider to obtain income

I am always looking for high quality FTSE dividends, instead of growth, stocks. I believe in the 'bird in hand' theory: I prefer that they pay me in cash (in the form of dividends) now than waiting for growth tomorrow.

Of course, long -term investment is balance and diversification. The main dividend payers today may not be the same in 10 or 20 years. Likewise, dividend policies are subject to changes that could quickly alter the balance of a portfolio.

However, there is something to say for the great stocks of FTSE 100 dividends stable in defensive or non -cyclic industries. I have chosen two of my current favorites that investors should consider to obtain additional performance.

Leading Biotechnology Company in the Industry

GSK (LSE: GSK) is one of the FTSE 100 stocks that I have seen. The actions of the biotechnological/pharmaceutical giant have dropped 9.5% in the last 12 months and are in £ 15.14 while writing on March 21.

The tariff warfighter that President Trump, combined with the threat of a reduction in HIV financing, has pressed the company's valuation in recent times.

However, I like GSK as a market leader in a non -cyclical industry that pays generously. Their shares have a dividend yield of 4%, above the average feet of 3.5%.

Another factor that I like is the size. GSK is a giant of the United Kingdom Grand Capitalization Index with a market limit of £ 62 billion. Add your rich story as a dividend payer and is certainly one to look.

I also like their friendly policies for shareholders. The Management recently announced that the additional 2 billion to shareholders will be returned within 18 months after its results date for the fiscal year24.

Of course, geopolitical risk increases for a multinational corporation like GSK. If we are more Tit rates per eye, they could exert more pressure on the price of the shares.

That adds to the long data risks that face market leaders in the industry, such as the uncertain success of drug trial and unforeseen regulatory changes.

The best consumption actions

The other footsie dividend shares that investors consider at this time is J Sainsbury (LSE: SBRY). The supermarket giant also has a history of consistent dividend payments and operates in a typically non -cyclic industry.

The groceries are a fiercely competitive business and the margins are thin. There is Tesco to compete with among many others trying to compete in the product range and the price.

However, Sainbury's is a strong brand and has a market limit of £ 5.6 billion at this time. When considering the current company of the company of 5.5%, I think it is one that could have some merit.

It carries significant liabilities in its balance sheet with a net debt position (including lease liabilities) of £ 5.5 billion. Of course, the use of leverage can amplify the yield of capital for the company's shareholders, but increases the risk of financial stress or breach.

The supermarket game can quickly change in the form of product shortage, new participants and price wars. While I think that J Sainsbury's greatest performance can compensate for this compared to colleagues, it is not cheap given a price to profits (p/e) of 34.

Verdict

These are only two of my FTSE 100 current Figidos Actions that I think is worth taking a look.

Each has a solid market position in typically defensive industries. That could make them good candidates to add some performance to a diversified portfolio of purchase and retention.